Neo-Angin (Amylmetacresol, Levomenthol, 2,4 Dichlorobenzyl Alcohol)

Amylmetacresol and 2,4‑dichlorobenzyl alcohol disrupt bacterial cell membranes, providing broad‑spectrum antiseptic activity. Levomenthol activates cold‑sensitive TRPM8 receptors, creating a cooling sensation and mild analgesic effect that soothes the mucosa while the antiseptic components limit microbial growth.

The appropriate dose of Neo‑Angin is determined by the prescribing healthcare professional or according to the product label instructions. Typical over‑the‑counter use involves dissolving one lozenge in the mouth every few hours, but exact frequency should follow the guidance provided on the packaging or by a clinician.

Safety data for Neo‑Angin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using the product to weigh potential benefits against any unknown risks.

To order Neo‑Angin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Neo‑Angin combines three active antiseptic ingredients, offering both antimicrobial action and a cooling, analgesic effect. Compared with single‑ingredient lozenges such as those containing only menthol or benzocaine, Neo‑Angin provides broader bacterial coverage while also delivering a soothing sensation, making it a comprehensive option for mild throat discomfort.

Neo‑Angin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Neo‑Angin is intended for oromucosal use. The lozenge is placed in the mouth and allowed to dissolve slowly, ensuring the active ingredients coat the throat and oral mucosa. Do not chew or swallow the lozenge whole; allow it to melt completely for optimal effect.

The most serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and rare cases of severe oral irritation or anaphylaxis. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Neo‑Angin should be avoided by individuals with known hypersensitivity to any of its ingredients, children under two years of age unless directed by a healthcare professional, and persons with severe oral lesions or mucosal damage where additional irritation could worsen the condition.